Introduction
Decline in immune function has been well described in the setting of physiologic aging [1] [2] [3] [4] [5] [6] manifesting as impaired vaccine responses and diminution of antibody (Ab)-secreting cells [7, 8] with reduced numbers of lymph node germinal centers (GCs) [9] . CD4 T cells provide help to antigen-primed B cells to undergo proliferation, isotype switching, and somatic hypermutation resulting in the generation of long-lived plasma cells and memory B cells (MBCs; reviewed in [10] ). This help is mediated by a specialized CD4 T-cell subset known as T follicular helper (Tfh) cells, characterized by the expression of the lymphoid follicle homing receptor CXC chemokine receptor 5 (CXCR5), which is required for the cells to migrate to the GC. We and others have described a circulating counterpart of CXCR5 + Tfh cells known as peripheral Tfh (pTfh) cells that are easily accessible from peripheral blood samples and are able to induce B cell differentiation [11] [12] [13] [14] [15] [16] . Studies in healthy adults have documented the importance of pTfh expansion at day 7 or day 28 post vaccination for their association with influenza vaccine response [17] [18] [19] [20] [21] [22] . However, most of the reported studies of pTfh (defined as CXCR5 + memory CD4 T cells) describe the kinetics of expansion in either bulk pTfh or their phenotypic subsets, providing limited information about antigen reactivity, especially in the aging population and those aging with HIV infection. The phenotypic identity of the bulk pTfh cells in previous flu vaccine studies were highly variable between different labs, making it difficult to draw conclusive evidence related to their identity, specificity, and functionality [18] [19] [20] . Influenza vaccination is recommended in individuals considered to be at increased risk for influenza infection, including adults older than 65 y and all HIV-infected persons even if they are virologically suppressed on antiretroviral therapy (ART) [23] . Declining immunity against influenza vaccines has also been reported in HIV-uninfected elderly populations [24] [25] [26] . An intriguing feature of HIV infection is that the immune system is believed to undergo premature immune senescence [27] [28] [29] . Moreover, HIV+ persons of older age can have worse immune deficits than occurring as a natural consequence of aging [8, 30, 31] . This has gained added importance because the success of ART has led to rapid growth of virologically suppressed aging HIV + individuals, with adults >50 y expected to exceed 70% of all HIV/AIDS cases by 2020 [29, 32] . Thus, it is crucial to better understand the impact of HIV infection on the age-associated decline in immunity. We have demonstrated a decrease in immune response to influenza vaccines in HIV + menopausal women compared to uninfected agematched healthy controls [8] as well as in HIV + males and females of varying ages [14, 33] .
In order to understand the Ab response to influenza vaccine and the effect of aging with or without HIV infection, we conducted the present study in young and old HIV + and HIV -uninfected (healthy control [HC] ) participants who had already been classified as vaccine responders (VRs) and vaccine nonresponders (VNRs) based on their serologic responses to seasonal influenza vaccine [33, 34] . We focused on antigen-specific pTfh (Ag.pTfh) identified on the basis of antigen-induced up-regulation of molecules CD40L and CD69 rather than bulk pTfh of unknown specificities [35, 36] . Studies of functional attributes of Ag.pTfh cells with respect to VR and VNR status in the context of flu vaccination in healthy and HIV aging are not known. In this study, ex vivo quantitative and qualitative assessment of Ag.pTfh revealed key features of Ag.pTfh that favored vaccine responsiveness. In VRs, magnitude of response was impacted by both quality and quantity of Ag.pTfh cells, and these were compromised in old age in HCs and in young and old HIV + individuals. In VNRs, in contrast, Ag.pTfh were heavily weighted towards an inflammatory phenotype irrespective of age or HIV status. This is the first study in humans to report an association between Ag.pTfh dysfunction and VNR status in aging and in ART-controlled HIV + individuals. The insight gained by this study of Ag.pTfh in peripheral blood provides direction for identifying therapeutic targets for improving vaccine responses.
Results
Following ex vivo stimulation of peripheral blood mononuclear cells (PBMCs) with H1N1 antigen for 12 h, Ag.pTfh with dual expression of CD40L and CD69 were clearly discernible within bulk pTfh cells defined as CXCR5 + memory CD4 T cells (CD45RO + CD27 + ) ( Fig 1A) . Based on the variables of age (Young versus Old), HIV status (HC versus HIV + ), and vaccine response status (VR versus VNR), participants were divided into the following 8 groups: (1) young HC VRs, (2) young HC VNRs, (3) old HC VRs, (4) old HC VNRs, (5) young HIV + VRs, (6) young HIV + VNRs, (7) old HIV + VRs, and (8) old HIV + VNRs. Each group was investigated for quantitative and qualitative Ag.pTfh characterization at prevaccination (T0) and at 2 time points post vaccination (T1 and T2), with the goal of determining how VRs differ from VNRs.
VNRs exhibit lower frequencies of Ag.pTfh with failed expansion and proliferation post vaccination
In HCs, frequencies of Ag.pTfh in young and old VRs increased from T0 to T1 and T0 to T2 and were greater than the corresponding VNR groups at all 3 time points but were not different from one another ( Fig 1B and S1 Fig) . At T2, frequencies of Ag.pTfh in HCs correlated with the fold change (FC) H1N1 Ab titer at T2 (Table 1) . In HIV + young and old VRs, the increases of Ag.pTfh from T0 to T1 and T2 were not significant, but the frequencies were higher than VNRs at T1 and T2 in young, but not in old, HIV + individuals. Frequencies of Ag.
pTfh at T0 were not different between young and old HIV + persons, and expansion post vaccination in young HIV + VRs at T2 was significantly less than in young and old HCs. Old HIV + VRs showed a trend of greater frequencies of Ag.pTfh compared to old HIV + VNRs, but it did not reach significance at post-vaccination ( Fig 1B) . Frequencies of Ag.pTfh at T2 in HIV + individuals failed to show a correlation with FC in H1N1 Ab titer at T2 (Table 1) . VNRs in all groups showed similar Ag.pTfh frequencies, indicating that the failure to expand Ag.pTfh post vaccination is a characteristic feature of VNRs regardless of age or HIV status. To confirm H1N1-specific pTfh cell expansion, we measured in vitro pTfh proliferation following H1N1 antigen stimulation in PBMCs using the CellTrace dye dilution assay. Examples of the proliferating CellTrace dim pTfh cells in young HC VRs and VNRs are shown in Fig 1C. In agreement with the observed increase in ex vivo Ag.pTfh frequencies shown in Fig 1B, an increase in the frequency of proliferating pTfh cells at T2 in comparison to T0 was observed in both young and old HC VRs. Additionally, the frequencies of CellTrace dim pTfh cells in HC VRs (young and old) at T1 and T2 were higher than the corresponding HC VNRs (Fig 1D and  S1 Fig) . The same results were obtained in the HIV + VRs with CellTrace dim pTfh cells with the exception that the peak proliferating cells in HIV + young VRs was reduced relative to HC young VRs (Fig 1D and S1 Fig) . Frequencies of proliferating pTfh cells at T2 directly correlated with FC H1N1 Ab titer at T2 in both HC and HIV + individuals (Table 1) . H1N1 antigeninduced pTfh proliferation was absent in VNR groups irrespective of age or HIV status.
H1N1-induced interleukin 21 and inducible costimulator expression are impaired in Ag.pTfh from HIV + participants
To explore the qualitative characteristics of Ag.pTfh pre and post vaccination, we examined their ability to produce the Tfh signature cytokine interleukin 21 (IL-21) [10, 37, 38] following ex vivo stimulation of PBMCs with H1N1 antigen (Fig 2A) . In young HC VRs, an increase in the frequencies of IL-21 + Ag.pTfh was observed over time from T0 to T2, and frequencies were significantly higher than in young HC VNRs at T1 and T2. Moreover, at T2, the frequencies of IL-21 + Ag.pTfh cells in young HC VRs were greater than those in the VRs of all 3 other groups at T2. In old HC VRs, frequencies of IL-21 + Ag.pTfh showed an increase from T0 to T2, and frequencies were higher than the old HC VNRs (Fig 2B and S2 Fig) Given the importance of inducible costimulator ligand (ICOS-L) interactions during T celldependent Ab production [10, 39, 40] , we analyzed surface expression of ICOS on Ag.pTfh cells (Fig 2D) . While T0 ICOS expression was not different among any of the groups (mean 20%-30%), ICOS induction in young HC VRs after vaccination followed a similar pattern as IL-21 and was induced maximally at T2, at which time point it was greater than that at T2 in all 3 other groups. ICOS was induced to a lower magnitude in old HC VRs, and not at all in HIV + young and old VRs (Fig 2E and S2 Fig) . Moreover, VNRs from all groups failed to increase ICOS expression on Ag.pTfh post vaccination irrespective of age or HIV status ( Fig 2E and S2  Fig) 
VNRs produce higher Tfh antagonistic and inflammatory cytokines post vaccination
To investigate the mechanisms of Ag.pTfh dysfunction in VNRs, we measured induction of additional cytokines, including IL-2, IL-17, and tumor necrosis factor alpha (TNF-α) ( Fig 3A,  3D and 3G). Frequencies of Ag.pTfh producing IL-2 ( Fig 3B and S2 Fig) , IL-17 ( Fig 3E and S2  Fig) , and TNF-α ( Fig 3H and S2 Fig) the old HIV + VNR group, the percentage of Ag.pTfh producing IL-2 and TNF-α at T2 was not significantly different than VRs but did show a significant increase at T2 compared to T0. IL-2 has been shown to antagonize Tfh differentiation [41] [42] [43] , and our data show that in young HCs and young HIV + VRs, IL-2 levels decreased significantly from T0 to T2 (Fig 3B) . Baseline expression levels of these cytokines were not different between the study groups, showing that the observed effects were a result of influenza vaccination. Furthermore, T2 expression of all 3 cytokines had a negative correlation with FC H1N1 Ab titer in HCs, while IL-2 and IL-17 were 
Baseline immune activation in bulk pTfh cells is detrimental to Ag.pTfh frequency and ICOS induction post vaccination
We recently reported a negative association between activated pTfh at T0 and influenza vaccine response in this cohort [34] . We used co-expression of CD38 and Human Leukocyte Antigen-DR isotype (HLA-DR) (with or without programmed cell death protein 1 [PD1]) on pTfh cells as a measure of immune activation and evaluated whether the basal state of activation in pTfh influenced Ag.pTfh characteristics at T2 (Fig 4) . Data for the correlation coefficient (r) and p-values are shown in S1 Table) . These data support baseline immune activation as a potential mechanism for reduced Ag.pTfh frequencies and impaired ICOS induction on Ag.pTfh in some influenza vaccine recipients.
Key variables associated with influenza Ab titer response in HCs and HIV

+ individuals
In our univariate correlation analysis between the T2 Ag.pTfh properties and FC H1N1 Ab titer in the HC and HIV + individuals, we found significant associations in HCs (Table 1) , but in HIV + individuals, associations of FC H1N1 Ab titer and Ag.pTfh frequency and key molecules such as IL-21 and ICOS were lacking. In order to identify the most important variables for Ab response in each group, we used the statistical method least absolute shrinkage and selection operator (LASSO) [45] and partial least squares discriminant analysis (PLSDA). Twenty-six antigen-specific measures-including those identified after in vitro stimulation of PBMCs with H1N1 antigen-and bulk pTfh data collected longitudinally at T0 and T2 were entered as x-variables for LASSO analysis using the FC H1N1 Ab titer as the outcome (S2 Table) . This analysis generated "predictive" models containing variables that were able to segregate VRs and VNRs in HCs ( Fig 5A) and HIV + individuals ( Fig 5C) at T0 as well as "correlative" models with variables that could segregate VRs and VNRs at T2 (Fig 5B and 5D ). For HCs, 4 variables at T0 and 3 variables at T2 were selected by LASSO for their association with FC H1N1 Ab titer (Tables 2 and 3 ). At T0, frequencies of Ag.pTfh and IL-21 + Ag.pTfh had a positive association, whereas IL-17 + and IL-2 + Ag.pTfh cells were negatively associated with Heatmap showing correlation coefficients between immune activation parameters in bulk pTfh cells at T0 with Ag. pTfh characteristics, including frequency, ICOS expression, and TNFα production at T2. All correlation analysis were performed by including VRs and VNRs together for HC (blue) and HIV + (red) groups. Colored boxes represent correlation coefficient for each comparison, and scale indicates positive r value (green) and negative r values (purple). For correlation analyses, either Pearson or Spearman rank correlation coefficient was performed based on data distribution.
� p < 0.05 indicates significant correlations (see also S1 Table) . Underlying data used in the generation of this figure can be found in S1 Data. Ag.pTfh, antigen-specific peripheral T follicular helper; HC, healthy control; ICOS, inducible costimulator; pTfh, peripheral T follicular helper; TNFα, tumor necrosis factor alpha; VNR, vaccine nonresponder; VR, vaccine responder. 
Ex vivo IL-21 supplementation along with IL-2 and TNF neutralization during pTfh:B cell interaction partially rescues Ag.pTfh defects and improves B cell function in VNRs
To further investigate the influence of the cytokine microenvironment on pTfh helper function, we performed coculture experiments using purified pTfh, MBCs, and antigen presenting cells (APCs) collected at T2 from HIV + and HC VRs and VNRs. Cell mixtures were cultured with H1N1 antigen in the presence and absence of a cytokine cocktail containing recombinant IL-21 along with neutralizing Abs against IL-2 (anti-IL-2) and TNF (anti-TNF) and then analyzed for IgG in the supernatant and B and pTfh phenotypes by flow cytometry. B cells + pTfh cells were evaluated by flow cytometry in the cocultures. For unpaired data, Mann-Whitney U test and for paired data Wilcoxon signed rank test was performed. p < 0.05 was considered significant. Line with stars indicates difference between the conditions and groups and the level significance as � p < 0.05; �� p < 0.01; ��� p < 0.001. Underlying data used in the generation of this figure can be found in S1 Data. Ag, antigen; APC, antigen presenting cell; CXCR5, CXC chemokine receptor 5; ICOS, inducible costimulator; IL-21, interleukin 21; anti-IL-2, antibody against interleukin 2; MBC, memory B cell; PBMC, peripheral blood mononuclear cell; PD1, programmed cell death protein 1; pTfh, peripheral T follicular helper; TNFα, tumor necrosis factor alpha; VNR, vaccine nonresponder. We also analyzed the phenotypic characteristics of pTfh cells after coculture for the expression of ICOS, Ki67, and PD1. ICOS expression on pTfh cells was strongly up-regulated by the cytokine cocktail treatment in VNRs (Fig 6B) . Analysis of Ki67 on pTfh cells showed that pTfh proliferation was higher in both HCs and HIV + VRs compared to VNRs. In the VNRs, the cytokine cocktail resulted in an increase in Ki67 + pTfh cells in both HCs and HIV + individuals (Fig 6C) . PD1 + pTfh cells were higher in the VNRs irrespective of HIV status, with maximum expression in cultures in the absence of APCs (Fig 6D) . The cytokine cocktail condition showed a trend of further lowering the PD1 expression on pTfh cells from both HCs and HIV + VNRs. Analysis of Th1, Th2, and Th17 pTfh subsets as defined by the expression of chemokine receptors CC chemokine receptor 4 (CCR4), CCR6, and CXC chemokine receptor 3 (CXCR3) [13] showed a significant increase in frequencies of the Th2 (CCR4 These results suggest that in VNRs, phenotypic and functional alterations of pTfh cells characterized by lower ICOS and higher PD1 expression, may impair their B cell helper function. The cytokine cocktail treatment and the presence of APCs in cocultures could partially rescue these altered phenotypic and functional profiles of pTfh cells in VNRs.
Discussion
The identification of precise immune correlates of vaccine responses is crucial to the search for biomarkers that predict immune responses to vaccines and for the identification of targets for intervention. We and others have previously shown that the subset of CD4 T cells defined as circulating or pTfh cells are important determinants of immune response to influenza vaccines. In the present study, our goal was to delineate characteristics of Ag.pTfh between established VR and VNR adults in the context of chronologic age and virologically suppressed HIV infection. The antigen-induced up-regulation of molecules CD40L and CD69 on pTfh was used for defining Ag.pTfh cells [46] . We demonstrate that compared to VNRs, Ag. pTfh cells in VNRs could be attributed, at least in part, to a defect in activin A production. Activin A is a protein recently described to drive Tfh differentiation [44] , levels of which were significantly lower in HIN1-stimulated PBMC culture supernatants in VNRs at T0 and T2. Activin A is strongly induced by monocytes during CD40/CD40L-mediated cognate interaction with activated T cells [47] .
We ) and found that VNRs had higher frequencies of CXR3+CCR6+ cells. Based on our findings, we posit that both aging and HIV infection may negatively influence the IL-21/IL-2 axis in Ag.pTfh and may thereby impact the vaccine response, possibly by affecting ICOS expression Ag.pTfh.
Induction of ICOS expression in Ag.pTfh cells at T2 was found to be an important determinant of their functional capability, correlated with vaccine responses, and was highest in young HC VRs. ICOS-ICOSL interactions are known to be important for Tfh:B cell interaction and also for IL-21 gene transcription in Tfh cells through c-Maf [57, 58] . In HCs, direct correlation between IL-21 + Ag.pTfh and ICOS + Ag.pTfh indicates the relevance of ICOS in induction of IL-21 in pTfh cells; in HIV + individuals, this association was absent irrespective of age. The association of ICOS expression on pTfh cells and vaccine responses has been established in several recent studies using bulk pTfh cells with varying phenotypes in healthy adults for influenza vaccine [17, 18, 20 ] as well as in 3 different human HIV vaccine trials [59] . In fact, a previous study using tetramer staining and activation-induced marker (AIM) assay demonstrated an expansion of the Ag.pTfh population post influenza vaccination, with co-expression of ICOS and CD38 and IL-21 production in young HCs [19] . Here, the ICOS + CD38 + pTfh correlated strongly with the circulating plasmablast response. However, in our study, we did not include CD38 as a marker of Ag.pTfh, because we found an age-associated decline in CD38 on pTfh cells [34] . Ours is the first study investigating ICOS expression on Ag.pTfh cells in the context of aging and HIV and points to the importance of studying Ag.pTfh compartment because the age-associated defects in ICOS induction post vaccination are not readily apparent in bulk pTfh.
pTfh dysfunction and flu vaccine response in aging and HIV infection
There is accumulating evidence for the deleterious effects of inflammation on immune response [6, [60] [61] [62] , for which the role of IL-2 in promoting TNF-α within activated T cells [63] is especially relevant for this study. Induction of proinflammatory cytokines TNF-α and IL-17 in Ag.pTfh were both increased in VNRs in all groups at T2. Indeed, the increased induction of TNF-α + Ag.pTfh cells from VNRs at T2 was negatively correlated with Ab titer and FC T2/T0 response in HCs, and TNF-α + Ag.pTfh were strongly correlated with IL-2 + Ag. pTfh in both HIV + individuals and HCs at T0. Proinflammatory IL-17 has been linked with various autoimmune and inflammatory disorders [64, 65] and also with aging in mice [66] . A role of these cells in the production of self-reactive Ab and the formation of dysregulated GCs in autoimmune disease has been established in mouse models [67] . Because HIV infection induces severe depletion of Th17 cells in the gut and impairs the gut integrity [68] , further studies are needed to establish the relevance of circulating IL-17 cells are higher in VNRs. We also analyzed whether Cytomegalovirus (CMV) serostatus had an influence on Ag.pTfh frequency and function as CMV infection can significantly affect Ab responses to the influenza vaccine in aging and HIV infection [70] [71] [72] [73] . In our study groups, CMV serostatus was higher in the HIV + individuals compared to HCs but did not correlate with age or Ab response to flu vaccination [74] . Although we did not measure CMV IgG titer in these participants, CMV serostatus did not show any association with Ag.pTfh frequency and function (not shown).
To further investigate the role of the cytokine microenvironment on pTfh and B cell function, we performed coculture experiments using purified pTfh, MBCs, APCs, and a cocktail containing cytokine IL-21-along with anti-IL-2 and anti-TNF-α neutralizing Abs-to antagonize the effect of exogenous IL-2 and TNF-α during T cell:B cell interactions. The results confirmed the pTfh defects in VNRs and the importance of the ICOS on pTfh cells for their helper function. In VNRs, the B cell function partially recovered in the presence of the cocktail of exogenous IL-21 and neutralizing Abs against IL-2 and TNF-α, increase in ICOS expression, and lowering of PD1 expression on pTfh cells, corroborating the detrimental impact of the IL-2 and TNF-α signaling on molecules associated with pTfh function. In both HCs and HIV + individuals, addition of APCs to the pTfh:B cell cocultures without cytokine cocktail enhanced ICOS expression and lowered PD1 in pTfh in VNRs and enhanced the polarization of Th2 pTfh in VRs. It is interesting to note that in VNRs, addition of APCs to the pTfh:B cell cocultures without cytokine cocktail reduced PD1 expression but failed to increase ICOS expression and IgG production, suggesting a primary role of ICOS over PD1 in enhancing the IgG production in this system. Further studies are needed to understand the pTfh plasticity associated with immune function and signaling events associated with APC:pTfh:B cell interactions that could determine the B cell function in VNRs. These studies are warranted to identify molecules that could be targeted for improving the ICOS signaling and overcoming the detrimental effect of activation induced PD1 signaling on pTfh functions in VNRs.
We used the LASSO model to further identify the antigen-specific T-cell characteristics that have predictive as well as correlative significance for the magnitude of vaccine response in HIV + individuals and HCs. The LASSO method has been used to identify key variables from large, complex datasets contributing to particular outcomes such as protective HIV vaccine Ab profiles [75] and spontaneous control of HIV disease [76] . We identified the predictive potential of the quantity (frequency) and the quality of the Ag. 
Materials and methods
Ethics statement
This study was approved by the institutional review boards of the University of Miami (20130399) and Miami Veterans Affairs Medical Center (1160374) and was carried out in accordance with approved guidelines. All the participants were adults, and voluntary written informed consent was obtained from every participant prior to participating in the study, including consent to have their samples stored for future use.
Study description and participants
Study participants were selected from project FInding Novel Determinants of Flu Responses (FIND), a substudy of FLORAH in which H1N1-specific Ab responses were determined in HIV + individuals and HCs of different ages [74] . Ab response to H1N1/09 vaccine antigen (H1N1 A/California/07/2009) was determined in serum by hemagglutination inhibition (HAI) assay [8, 14, 31] . Participants with H1N1 Ab titers of �1:40 and a �4-fold increase at 4 wk post vaccination were classified as VRs as defined by the Food and Drug Administration (FDA), and those who did not meet these criteria were classified as VNRs [77] . The study population of FIND was restricted to participants with a prevaccination H1N1 Ab titer of �1:320 to prevent a person from being classified as a VNR due to the presence of a high prevaccination titer and consequent failure to achieve a 4-fold increase in titer post vaccination [74] . Study participants were recruited during the 2013-2014, 2014-2015, and 2015-2016 influenza seasons, with each participant being unique for one of the 3 vaccine seasons. Characteristics of the study participants are depicted in Table 6 . HIV + individuals and HCs were grouped by age into young (<40 y), with 20 HIV + individuals and 18 HCs, and old (�60 y), with 30 HIV + individuals and 35 HCs. The HIV + participants were on cART with virologic suppression (plasma HIV RNA < 40 copies/ml) for �1 y prior to study entry. As established in the parent study, anyone on hormonal replacement therapy, steroids, or immunosuppressant medications or with a diagnosis of active malignancy or immunodeficiency disorder was excluded. CMV seropositivity was higher in the HIV + individuals compared with HCs for young and old age groups, although CMV status did not affect the age or H1N1 Ab response post vaccination [74] . All participants were given a single intramuscular dose of trivalent influenza vaccine (TIV; Seqirus, PA). HIV + individuals were vaccinated as standard of care at the University of Miami and Miami Veteran Affairs Medical Center. Peripheral venous blood was collected pre vaccination (at T0), on day 7 (T1), and on day 21-28 (T2). Serum and plasma were stored at −80˚C, and PBMCs were cryopreserved in liquid N 2 . Absolute CD4 and CD8 T-cell counts, geometric mean H1N1 titer (GMT), and FC H1N1 Ab titer at T2 over T0 (FC) for participants classified as VRs and VNRs in different age groups are shown in Table 6 . At T0, the participants were similar in absolute numbers of CD45, CD3, CD4, CD8, CD4/CD8 
CD4/CD8 ratio 2.5 ± 1.5 2.9 ± 2.4 2.8 ± 1.1 2.5 ± 2.0 2.5 ± 2.5 2.6 ± 0.9 2.4 ± 2.5 2.5 ± 1.4
B cells (%) 9 ± 5.6 10.5 ± 6 10.5 ± 5 9.1 ± 7 8.1 ± 4 9.5 ± 5 11.4 ± 6 11 ± 6.6
GMT of H1N1 pTfh dysfunction and flu vaccine response in aging and HIV infection ratio, and B cell frequencies. The GMT at T2 and FC was highest in young HC VRs compared to all other groups.
Monoclonal antibodies
The following fluorochrome conjugated antihuman monoclonal antibodies (MoAbs) were used for flow cytometry studies: ICOSBV421, ICOSAlexa488, CD40LBV605, CD69BV650, HLA-DRFITC, CD38APCCy7, and TNF-αAPCCy7 from BioLegend (San Diego, CA); CD3BUV395, CD4PerCPCy5.5, CD8Alexa-Fluor700, CCR7PECF594, IL-2BV711, CXCR5A-lexa647, IFNγPE-Cy7, PD1BV650, CD45ROAPCH7, CD21PECy5, CD27PerCPCy5.5, IgDFITC, CD10PECy7, and CD20Alexa700 from BD Bioscience (San Jose, CA); IL-21PE, CD27PECy5, and IL-17Alexa488 from e-Biosciences ( stimulated PBMCs, and further characterized for intracellular expression of cytokines IL-21, IL-2, TNF-α, and IL-17. Briefly, cryopreserved PBMCs were thawed, rested overnight, washed, suspended at 1.5 million/ml and cultured with both anti-CD28 and anti-CD49d MoAbs at 1μg/ml each and with 5μg/mL H1N1/09 vaccine antigen (gift by Seqirus, PA) at 37˚C and 5% CO 2 for 12 hrs. Cells cultured with only anti-CD28, anti-CD49d as negative controls (medium), and cultured with 1μg/ml SEB (List Biological Labs, CA) served as positive controls. The secretion inhibitor Brefeldin A (10 μg/mL) was added to all cultures for the last 7 h of incubation. Thereafter, cells were washed and surface stained with Live/Dead Aqua for 20 min on ice followed by staining for surface markers CD3, CD4, CD8, CD45RO, CD27, ICOS and CXCR5, fixed, permeabilized and stained for intracellular activation markers CD40L, CD69 and cytokines IL-2, IL-21, IL-17, and TNF-α. Cells were suspended in 1% paraformaldehyde and acquired on a BD LSRFortessa flow cytometer. Ag.pTfh cells were determined as live + pTfh in unstimulated condition was subtracted from values in H1N1 stimulated condition in each individual to get a precise readout for antigen specificity above background levels.
H1N1 antigen-specific T-cell proliferation at T0, T1 and T2
Thawed PBMCs were rested overnight as described above and labelled with CellTrace violet proliferation tracker dye. 1.5 million/ml CellTrace labelled PBMCs were then incubated with 5μg/mL H1N1/09 vaccine antigen. Cells in medium without any antigen served as negative controls (medium), while cells with SEB at 1μg/ml served as positive controls. Cultures were incubated for 5 d at 37˚C in 5% CO 2 . On day 5, cells were harvested and culture supernatants were stored at -80˚C. Cells were stained with Live/Dead Aqua followed by staining for CD3, CD4, CD8, CD45RO, CD27, CXCR5 and ICOS, acquired and analyzed by flow cytometry. Proliferating cells were identified based on the CellTrace dye dilution. Frequencies of H1N1 specific proliferating cells (CellTrace dim ) were identified within pTfh compartments after and subtracted the values from the unstimulated conditions. Culture supernatants were collected and stored at -80˚C.
Cytokines, activin A, and CXCL13 from PBMC culture supernatants
Cytokines from PBMC culture supernatants were measured using a customized MILLIPLEX Human Cytokine magnetic bead panel (EMD Millipore) or by ELISA following the manufacturer's instructions [34] . Briefly, culture supernatants were thawed, and centrifuged at 1,000 g for 3 min prior to testing. Undiluted culture supernatants were incubated overnight with a mixture of beads specific for IL-2, IL-17, and TNF-α at 4˚C with shaking. The mean fluorescence intensity (MFI) data were analyzed with MILLIPLEX Analyst Software V.3.5 (EMD Millipore) and cytokine concentrations were expressed in pg/ml. Activin A (R&D systems) were measured by ELISA and expressed as pg/ml.
Resting MBCs and H1N1-specific IgG-secreting MBCs at T2
B cell phenotypic subsets were analyzed by flow cytometry using cryopreserved PBMCs as described previously [22, 31, 33, 78] . Briefly, cells were stained with Live . H1N1-specific IgG-secreting MBCs were identified by MBC ELISPOT assay after culturing PBMCs with H1N1 antigen for 5 d as described [8, 33] .
Immune activation of bulk pTfh at T0
Thawed PBMCs were rested overnight and stained with Live/Dead Aqua followed by staining for CD3, CD4, CD8, CD45RO, CD27, CCR7, activation (HLA-DR, CD38, PD1), and CXCR5 and acquired by FC 
Cell sorting
We included 
Statistical methods
For Ag.pTfh function including proliferation, cells with medium were used as negative controls to identify the background response which was subtracted from the antigen-stimulated cultures to determine the H1N1 induced response. Group and time analyses used generalized linear mixed models to accommodate the repeated measure of time. The first analysis looked at time differences in the outcomes for each group separately. Planned comparisons among the 3 times were made. The other analyses compared the outcomes between 2 different groups at each time. Planned comparisons were made between the 2 groups at each time. For Correlation analyses, Spearman correlation was used assess the strength of the relationships among the outcomes with age and H1N1 titers at each time for different selected groups. The data are presented as scatter plots with regression lines and correlation coefficients with p values. A p value of <0.05 was considered as significant. SAS 9.4 (SAS Institute, Cary, NC) was used for all analyses. For LASSO analysis, data was log2+1 transformed and univariate linear regression was performed on each independent variable. Feature selection to find a best prediction model was performed using R package glmnet with LASSO or elastic-net regularization. Firstly data was randomly split to train (2/3) and test (1/3) [79] . Then repeated-corrected 10-fold cross validation for glmnet was performed. Variables at both LambdaMin and Lambda1SE were extracted [79] . For continuous outcome variable, fit linear regression was performed on variables selected from either LambdaMin or Lambda1SE. The model with highest adjusted R square and p-value <0.05 was selected as the best model. Hypothesis tests for reliability of the best model were performed using ANOVA (Analysis of Variance) F test. Type I, Type II and Type III Sums of Squares (SS) tests were conducted to test the significance of regression. For discrete outcome variable (Response VNR/VR), PLSDA was performed on variables selected from best model to classify VNR/VR samples using R package mixOmics [80] . 
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